Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease.

Chia-Chen ChenChi-Ya HuangJheng-Yen WuMei-Yuan LiuMin-Hsiang ChuangTing-Hui LiuYa-Wen TsaiWan-Hsuan HsuPo-Yu HuangMing-Hui ChenSu-Yen LiuMei-Chuan LeeKuo-Chuan HungChih-Cheng LaiI-Ning Yang

Published in: Expert review of anti-infective therapy (2024)

Oral antiviral agents could be associated with lower rates of all-cause hospitalization or death among non-hospitalized COVID-19 patients with CKD.

Keyphrases

sars cov
coronavirus disease
randomized controlled trial
chronic kidney disease
systematic review
respiratory syndrome coronavirus